Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.

Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Baiocchi GC, Freire PP, Filgueiras IS, Zyskind I, Lattin MT, Tran F, Schreiber S, Marques AHC, Plaça DR, Fonseca DLM, Humrich JY, Müller A, Giil LM, Graßhoff H, Schumann A, Hackel A, Junker J, Meyer C, Ochs HD, Lavi YB, Scheibenbogen C, Dechend R, Jurisica I, Schulze-Forster K, Silverberg JI, Amital H, Zimmerman J, Heidecke H, Rosenberg AZ, Riemekasten G, Shoenfeld Y

Open source

DOI: 10.1038/s41467-022-28905-5
Published: 2022 Mar 9
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-022-28905-5,
  title = {Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.},
  author = {Cabral-Marques O and Halpert G and Schimke LF and Ostrinski Y and Vojdani A and Baiocchi GC and Freire PP and Filgueiras IS and Zyskind I and Lattin MT and Tran F and Schreiber S and Marques AHC and Plaça DR and Fonseca DLM and Humrich JY and Müller A and Giil LM and Graßhoff H and Schumann A and Hackel A and Junker J and Meyer C and Ochs HD and Lavi YB and Scheibenbogen C and Dechend R and Jurisica I and Schulze-Forster K and Silverberg JI and Amital H and Zimmerman J and Heidecke H and Rosenberg AZ and Riemekasten G and Shoenfeld Y},
  year = {2022},
  journal = {Nature communications},
  doi = {10.1038/s41467-022-28905-5},
  url = {https://doi.org/10.1038/s41467-022-28905-5}
}

RIS

TY  - JOUR
TI  - Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
AU  - Cabral-Marques O
AU  - Halpert G
AU  - Schimke LF
AU  - Ostrinski Y
AU  - Vojdani A
AU  - Baiocchi GC
AU  - Freire PP
AU  - Filgueiras IS
AU  - Zyskind I
AU  - Lattin MT
AU  - Tran F
AU  - Schreiber S
AU  - Marques AHC
AU  - Plaça DR
AU  - Fonseca DLM
AU  - Humrich JY
AU  - Müller A
AU  - Giil LM
AU  - Graßhoff H
AU  - Schumann A
AU  - Hackel A
AU  - Junker J
AU  - Meyer C
AU  - Ochs HD
AU  - Lavi YB
AU  - Scheibenbogen C
AU  - Dechend R
AU  - Jurisica I
AU  - Schulze-Forster K
AU  - Silverberg JI
AU  - Amital H
AU  - Zimmerman J
AU  - Heidecke H
AU  - Rosenberg AZ
AU  - Riemekasten G
AU  - Shoenfeld Y
PY  - 2022
JO  - Nature communications
DO  - 10.1038/s41467-022-28905-5
UR  - https://doi.org/10.1038/s41467-022-28905-5
ER  -

APA

O, C., G, H., LF, S., Y, O., A, V., GC, B., PP, F., IS, F., I, Z., MT, L., F, T., S, S., AHC, M., DR, P., DLM, F., JY, H., A, M., LM, G., H, G., A, S., A, H., J, J., C, M., HD, O., YB, L., C, S., R, D., I, J., K, S., JI, S., H, A., J, Z., H, H., AZ, R., G, R., & Y, S. (2022). Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.. Nature communications. https://doi.org/10.1038/s41467-022-28905-5

Source records

pubmed · retrieved 2026-09-26T05:52:14.501Z